Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Early-Stage TNBC: What are the Roles of PARPIs?

Access Activity

Overview / Abstract:

Explore the latest groundbreaking treatment approaches for early-stage triple-negative breast cancer (TNBC) in this engaging tumor board! The multidisciplinary panel of expert faculty will dive into a case involving a patient with early TNBC and discuss the latest data and potential roles of PARP inhibitors (PARPIs) in the first CME activity offered in this TNBC series.

TNBC is an aggressive disease that disproportionately affects African American women in the United States. Treatment options are limited for TNBC compared with other types of breast cancer, but new therapies hold promise for improved patient outcomes. This activity aims to help the multidisciplinary TNBC team with practical strategies to integrate evidence-based treatment options, particularly PARPIs, into practice.

Expiration

Aug 03, 2023

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Online

Credits / Hours

0.50 AMA PRA Category 1 Credit(s)

Accreditation

ACCME

Presenters / Authors / Faculty

Sarah Blair, MD; Sarah Donahue, MPH, NP, AOCNP; Amir Momeni-Boroujeni, MD; Rita Nanda, MD

Sponsors / Supporters / Grant Providers

Supported by an independent educational grant from Gilead Sciences, Inc.

Keywords / Search Terms

ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Webcasts, Newsletter, Case Study, University of Chicago Pritzker School of Medicine Center for Continuing Medical Education, University of Chicago, triple-negative breast cancer, TNBC, Trop2, antibody drug conjugate (ADC), oncologist, oncology, breast cancer, racial disparities, estrogen, receptor, progesterone Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map